{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:45:21Z","timestamp":1791935121225,"version":"4.3.4"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Human immunodeficiency virus (HIV) testing is the first step in the HIV prevention cascade. The Centers for Disease Control and Prevention HIV laboratory diagnostic testing algorithm was developed before preexposure prophylaxis (PrEP) and immediate antiretroviral therapy (iART) became standards of care. PrEP and iART have been shown to delay antibody development and affect the performance of screening HIV assays. Quantitative results from fourth-generation HIV testing may be helpful to disambiguate HIV testing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively reviewed 38\u2005850 results obtained at an urban, academic medical center. We assessed signal-to-cutoff (s\/co) distribution among positive and negative tests, in patients engaged and not engaged in an HIV prevention program, and evaluated changes in patients with multiple results. Classification and regression tree (CART) analysis was used to determine a threshold cutoff, and logistic regression was used to identify predictors of true positive tests.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Ninety-seven percent of patients with a negative HIV test had a result that was \u22640.2\u2005s\/co. For patients tested more than once, we found differences in s\/co values did not exceed 0.2\u2005s\/co for 99.2% of results. CART identified an s\/co value, 38.78, that in logistic regression on a unique validation cohort remained associated with the likelihood of a true-positive HIV result (odds ratio, 2.49).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Machine-learning methods may be used to improve HIV screening by automating and improving interpretations, incorporating them into robust algorithms, and improving disease prediction. Further investigation is warranted to confirm if s\/co values combined with a patient's risk profile will allow for better clinical decision making for individuals on PrEP or eligible for iART.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofac259","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T14:42:06Z","timestamp":1652884926000},"source":"Crossref","is-referenced-by-count":7,"title":["Am I Positive? Improving Human Immunodeficiency Virus Testing in the Era of Preexposure Prophylaxis and Immediate Antiretroviral Therapy Using Machine Learning"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6987-6412","authenticated-orcid":false,"given":"Jason","family":"Zucker","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Carnevale","sequence":"additional","affiliation":[{"name":"Comprehensive Health Center HIV Prevention Program, New York Presbyterian Hospital, \u00a0 New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena E","family":"Sobieszczyk","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3734-4590","authenticated-orcid":false,"given":"Alex J","family":"Rai","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center , New York, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"2022073010010574500_ofac259-B1","first-page":"21263","article-title":"Towards an integrated primary and secondary HIV prevention continuum for the United States: a cyclical process model","volume-title":"J Int AIDS Soc","author":"Horn","year":"2016"},{"key":"2022073010010574500_ofac259-B2","article-title":"2015 blueprint on ending the AIDS epidemic","author":"New York State Department of Health AIDS Institute","year":"2016"},{"key":"2022073010010574500_ofac259-B3","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2020.17025","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society\u2013USA panel","volume":"324","author":"Saag","year":"2020","journal-title":"JAMA"},{"key":"2022073010010574500_ofac259-B4","first-page":"1","article-title":"Laboratory testing for the diagnosis of HIV infection: updated recommendations","author":"Centers for Disease Control and Prevention","year":"2014"},{"key":"2022073010010574500_ofac259-B5","article-title":"Suggested reporting language for the HIV laboratory diagnostic testing algorithm","author":"Association of Public Health Laboratories","year":"2013"},{"key":"2022073010010574500_ofac259-B6","article-title":"Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142021 update: a clinical practice guideline","author":"Centers for Disease Control and Prevention, US Public Health Service"},{"key":"2022073010010574500_ofac259-B7","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","article-title":"Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection","volume":"17","author":"Fiebig","year":"2003","journal-title":"AIDS"},{"key":"2022073010010574500_ofac259-B8","article-title":"PrEP failure case underscores importance of regular HIV testing: an interview with Elske Hoornenborg","author":"Wilder","year":"2017"},{"key":"2022073010010574500_ofac259-B9","article-title":"Amsterdam PrEP Project in the HIV Transmission Elimination Amsterdam (H-team) Initiative. Acute infection with a wild-type HIV-1 virus in prep user with high TDF levels (abstract 953)","author":"Hoornenborg"},{"key":"2022073010010574500_ofac259-B10","article-title":"Newly acquired HIV-1 infection with multi-drug resistant (MDR) HIV-1 in a patient on TDF\/FTC based PrEP (video)","author":"Grossman","year":"2016"},{"key":"2022073010010574500_ofac259-B11","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S2352-3018(18)30288-1","article-title":"Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report","volume":"6","author":"Cohen","year":"2019","journal-title":"Lancet HIV"},{"key":"2022073010010574500_ofac259-B12","first-page":"ofy180","article-title":"A strategy for PrEP clinicians to manage ambiguous HIV test results during follow-up visits","volume-title":"Open Forum Infect Dis","author":"Smith","year":"2018"},{"key":"2022073010010574500_ofac259-B13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/cid\/ciw365","article-title":"Initiation of antiretroviral therapy during acute HIV-1 infection leads to a high rate of nonreactive HIV serology","volume":"63","author":"De Souza","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2022073010010574500_ofac259-B14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1086\/428127","article-title":"Incomplete HIV type 1 antibody evolution and seroreversion in acutely infected individuals treated with early antiretroviral therapy","volume":"40","author":"Kassutto","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2022073010010574500_ofac259-B15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/QAI.0b013e3182234a51","article-title":"Delayed maturation of antibody avidity but not seroconversion in rhesus macaques infected with simian HIV during oral pre-exposure prophylaxis","volume":"57","author":"Curtis","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022073010010574500_ofac259-B16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/QAI.0000000000001374","article-title":"Characterization of HIV seroconverters in a TDF\/FTC PrEP study: HPTN 067\/ADAPT","volume":"75","author":"Sivay","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022073010010574500_ofac259-B17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2101016","article-title":"Cabotegravir for HIV prevention in cisgender men and transgender women","volume":"385","author":"Landovitz","year":"2021","journal-title":"N Engl J Med"},{"key":"2022073010010574500_ofac259-B18","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1097\/QAI.0000000000002054","article-title":"Predictors of disengagement in care for individuals receiving pre-exposure prophylaxis (PrEP)","volume":"81:","author":"Zucker","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022073010010574500_ofac259-B19","doi-asserted-by":"crossref","volume-title":"Classification and regression trees","author":"Breiman","DOI":"10.1201\/9781315139470"},{"key":"2022073010010574500_ofac259-B20","volume-title":"RStudio: Integrated Development for R","author":"RStudio Team","year":"2015"},{"key":"2022073010010574500_ofac259-B21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/aid.2020.0137","article-title":"Altered antibody responses in persons infected with HIV-1 while using PrEP","volume":"37","author":"Parker","year":"2021","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022073010010574500_ofac259-B22","doi-asserted-by":"crossref","first-page":"e522","DOI":"10.1016\/S2352-3018(17)30132-7","article-title":"Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report","volume":"4","author":"Hoornenborg","year":"2017","journal-title":"Lancet HIV"},{"key":"2022073010010574500_ofac259-B23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/QAI.0000000000001534","article-title":"Newly acquired infection with multi-drug resistant HIV-1 in a patient adherent to pre-exposure prophylaxis","volume":"76:e","author":"Markowitz","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022073010010574500_ofac259-B24","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1097\/QAI.0000000000001665","article-title":"Positive or not, that is the question: HIV testing for individuals on pre-exposure prophylaxis","volume":"78","author":"Zucker","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2022073010010574500_ofac259-B25","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1128\/JCM.03583-14","article-title":"A signal-to-cutoff ratio in the Abbott Architect HIV Ag\/Ab combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting","volume":"53","author":"Jensen","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2022073010010574500_ofac259-B26","first-page":"399","article-title":"Longitudinal analysis of social and behavioral determinants of health in the EHR: exploring the impact of patient trajectories and documentation practices","volume-title":"AMIA Annu Symp Proc","author":"Feller","year":"2020"},{"key":"2022073010010574500_ofac259-B27","first-page":"422","article-title":"Towards the inference of social and behavioral determinants of sexual health: development of a gold-standard corpus with semi-supervised learning","volume":"2018","author":"Feller","year":"2018","journal-title":"AMIA Annu Symp Proc"},{"key":"2022073010010574500_ofac259-B28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/s-0040-1702214","article-title":"Detecting social and behavioral determinants of health with structured and free-text clinical data","volume":"11","author":"Feller","year":"2020","journal-title":"Appl Clin Inform"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofac259\/43750954\/ofac259.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/7\/ofac259\/45029018\/ofac259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/7\/ofac259\/45029018\/ofac259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T10:03:10Z","timestamp":1659175390000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofac259\/6588162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofac259","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,5,18]]},"article-number":"ofac259"}}